By Tushar Sharma , 6 September 2025

The Indian government’s decision to reduce the Goods and Services Tax (GST) on cement from 28% to 18% is poised to deliver significant relief to the infrastructure sector. Industry analysts suggest that this policy change could substantially lower construction costs for government and private projects, boosting profitability and accelerating project timelines. The move is expected to stimulate demand across segments such as housing, roads, and industrial construction, while providing a welcome boost to developers grappling with rising input costs.

By Binnypriya Singh , 6 September 2025

In a landmark development in India’s industrial and infrastructure sector, Vedanta Ltd. has successfully outbid Adani Group to acquire a controlling stake in JAL, a major water resources and utilities company. The acquisition underscores Vedanta’s strategic diversification into water management and critical infrastructure, signaling its intent to expand beyond metals and mining. Analysts view this move as a calculated effort to strengthen Vedanta’s long-term revenue streams amid increasing regulatory focus on sustainable water solutions.

By Gurjot Singh , 5 September 2025

IHG Hotels & Resorts, one of the world’s leading hotel chains, is significantly expanding its footprint in Bengaluru with the addition of 420 new keys across multiple properties. This strategic move reinforces IHG’s commitment to India’s booming hospitality sector, capitalizing on the city’s growing demand for business and leisure accommodations. Bengaluru’s status as a technology and business hub makes it a critical market for luxury and midscale hotel offerings.

By Eknath Deshpande , 5 September 2025

Tata Capital, one of India’s leading financial services firms, is gearing up for an initial public offering (IPO) valued at approximately USD 2 billion, marking a significant milestone in its growth trajectory. The IPO aims to raise capital to expand lending operations, enhance digital financial services, and strengthen the company’s balance sheet. By tapping public markets, Tata Capital seeks to deepen investor participation while leveraging India’s burgeoning demand for retail and corporate credit.

By Gurjot Singh , 5 September 2025

The Competition Commission of India (CCI) has granted approval to Sumitomo Mitsui Banking Corporation (SMBC) for acquiring a significant stake in Yes Bank, paving the way for deeper strategic collaboration between the two financial institutions. The acquisition strengthens Yes Bank’s capital base and aligns with its efforts to enhance financial stability and corporate governance. For SMBC, the investment provides a foothold in India’s expanding banking sector, complementing its global portfolio.

By Binnypriya Singh , 5 September 2025

Caplin Point Laboratories has received approval from the United States Food and Drug Administration (USFDA) for its Milrinone injection, a cardiovascular drug used in the management of heart failure and related conditions. The approval allows the Indian pharmaceutical firm to market the therapy in the U.S., a key market for high-value generic injectables. This milestone strengthens Caplin Point’s presence in the cardiovascular segment while showcasing its ability to meet stringent regulatory standards.

By Tushar Sharma , 5 September 2025

Shringar House, a leading Indian beauty and personal care retailer, has announced its initial public offering (IPO), setting a price band to attract retail and institutional investors. The IPO represents a strategic move to raise capital for expansion, enhance brand visibility, and strengthen its retail footprint across urban and semi-urban markets. With a growing consumer base and rising demand for personal grooming products, Shringar House is positioning itself to capture greater market share.

By Eknath Deshpande , 5 September 2025

Indian pharmaceutical giant Lupin has secured approval from the United States Food and Drug Administration (USFDA) for its generic Risperidone injection, a widely used treatment for schizophrenia and bipolar disorder. The approval allows Lupin to market the injectable formulation in the U.S., one of the world’s largest pharmaceutical markets. This regulatory milestone strengthens Lupin’s central nervous system (CNS) portfolio, expands its footprint in high-value generics, and demonstrates its capability to meet stringent international compliance standards.

By Gurjot Singh , 5 September 2025

Mumbai-based Arkade Developers has secured a prime land parcel in the city for Rs. 148 crore, marking a significant addition to its real estate portfolio. The acquisition highlights the company’s continued expansion in India’s most competitive property market, where land availability is limited and demand remains consistently high. Positioned to cater to both residential and commercial projects, the newly acquired site underscores Arkade’s strategy of strengthening its footprint in metropolitan hubs.

By Binnypriya Singh , 5 September 2025

The Indian Hotels Company Limited (IHCL), part of the Tata Group and a leading name in the hospitality industry, has announced the opening of a new property under its Gateway brand in Dwarka, New Delhi. Positioned as a modern and upscale offering, the hotel is expected to enhance the city’s growing hospitality landscape. Strategically located near the airport and major business districts, the hotel aims to cater to both business and leisure travelers.